格洛布斯醫療有限公司
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionEmpowered Funds, LLC
Latest Disclosed Ownership37,973 shares
Latest Disclosed Value $ 3,271,753
Empowered Funds, LLC reports 792.01% increase in ownership of GMED / Globus Medical, Inc.

On May 15, 2026 - Empowered Funds, LLC filed a 13F-HR form disclosing ownership of 37,973 shares of Globus Medical, Inc. (MX:GMED) valued at $3,271,753 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 4,257 shares of Globus Medical, Inc.. This represents a change in shares of 792.01% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GLOBUS MED CL A 379577208 37,973 33,716 792.01 3,272 781.67 0.0092
2026-02-11 2025-12-31 13F GLOBUS MED CL A 379577208 4,257 -110 -2.52 372 48.40 0.0030
2025-11-13 2025-09-30 13F GLOBUS MED CL A 379577208 4,367 75 1.75 250 -1.19 0.0025
2025-08-11 2025-06-30 13F GLOBUS MED CL A 379577208 4,292 -81,435 -94.99 253 -95.97 0.0029
2025-05-16 2025-03-31 13F GLOBUS MED CL A 379577208 85,727 8,295 10.71 6,275 -2.01 0.0893
2025-01-28 2024-12-31 13F GLOBUS MED CL A 379577208 77,432 77,432 6,404 0.0936
2023-04-05 2023-03-31 13F GLOBAL X FDS SUPERDVDND REIT 379577208 0 -7,852 -100.00 0 -100.00
2023-02-21 2022-12-31 13F/A-1 GLOBAL X FDS SUPERDVDND REIT 379577208 7,852 7,852 583 0.0381
2023-01-26 2022-12-31 13F GLOBAL X FDS SUPERDVDND REIT 379577208 7,852 7,852 1 0.0235
2019-05-10 2019-03-31 13F GLOBUS MED CL A 379577208 0 -24,234 -100.00 0 -100.00
2019-01-22 2018-12-31 13F GLOBUS MED CL A 379577208 24,234 -7,621 -23.92 1,049 -41.46 0.4439
2018-10-18 2018-09-30 13F GLOBUS MED CL A 379577208 31,855 31,855 1,792 0.5305
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.